ARTICLE | Company News
PathoGenesis infectious diseases news
April 10, 2000 7:00 AM UTC
PGNS formed Pathogenesis B.V. (Rotterdam, the Netherlands) to market its TOBI tobramycin in the Netherlands to treat chronic pulmonary Pseudomonas aeruginosa infections in cystic fibrosis patients. T...